Superbugs and antibiotics in the newborn

Antibiotic resistance has become an urgent and global issue, with 700,000 deaths attributable to multidrug-resistance occurring each year worldwide. The overuse of antibiotics, both in animal industry and in clinical settings, and the generated selective pressure, are the main factors implicated in...

Full description

Bibliographic Details
Main Authors: Alessandro Borghesi, Mauro Stronati
Format: Article
Language:English
Published: Hygeia Press di Corridori Marinella 2015-10-01
Series:Journal of Pediatric and Neonatal Individualized Medicine
Subjects:
Online Access:https://www.jpnim.com/index.php/jpnim/article/view/333
id doaj-fa0f0b766cee478b8ac74e496d7cec36
record_format Article
spelling doaj-fa0f0b766cee478b8ac74e496d7cec362020-11-25T01:26:58ZengHygeia Press di Corridori MarinellaJournal of Pediatric and Neonatal Individualized Medicine2281-06922015-10-0142e040253e04025310.7363/040253275Superbugs and antibiotics in the newbornAlessandro Borghesi0Mauro Stronati1Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyNeonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyAntibiotic resistance has become an urgent and global issue, with 700,000 deaths attributable to multidrug-resistance occurring each year worldwide. The overuse of antibiotics, both in animal industry and in clinical settings, and the generated selective pressure, are the main factors implicated in the emergence of resistant strains. The Centers for Disease Control and Prevention (CDC) have pointed out that more than half of hospital patients receive an antibiotic during their stay, and nearly a third receive a broad-spectrum antibiotic. In neonatal units, previous antibiotic exposure to third-generation cephalosporin and carbapenem were identified as independent risk factors for infection caused by multi-drug resistant strains. While resistant ‘superbugs’ emerge, the arsenal to fight these microorganisms is progressively shrinking, as the number of newly discovered antibiotics approved by the Food and Drug administration each year is dropping. In face of global spread of antibiotic resistance and of the limited development of new drugs, policies and rules are under study by agencies (CDC, World Health Organization) and governments, in order to: i) facilitate and foster the discovery of new antibiotic compounds; ii) develop new, alternative therapies able to potentiate or modulate the host immune response or to abrogate the resistance and virulence factors in the microorganisms; and iii) prevent the emergence of resistance through antibiotic stewardship programs, educational programs, and reduction of antibiotic use in livestock; the field of neonatal medicine will need its own, newborn-tailored, antibiotic stewardship programs to be implemented in the NICUs.   Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adult Guest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)https://www.jpnim.com/index.php/jpnim/article/view/333neonatal intensive careinfectionantibioticmulti-drug resistantcarbapenemaseantibiotic stewardship
collection DOAJ
language English
format Article
sources DOAJ
author Alessandro Borghesi
Mauro Stronati
spellingShingle Alessandro Borghesi
Mauro Stronati
Superbugs and antibiotics in the newborn
Journal of Pediatric and Neonatal Individualized Medicine
neonatal intensive care
infection
antibiotic
multi-drug resistant
carbapenemase
antibiotic stewardship
author_facet Alessandro Borghesi
Mauro Stronati
author_sort Alessandro Borghesi
title Superbugs and antibiotics in the newborn
title_short Superbugs and antibiotics in the newborn
title_full Superbugs and antibiotics in the newborn
title_fullStr Superbugs and antibiotics in the newborn
title_full_unstemmed Superbugs and antibiotics in the newborn
title_sort superbugs and antibiotics in the newborn
publisher Hygeia Press di Corridori Marinella
series Journal of Pediatric and Neonatal Individualized Medicine
issn 2281-0692
publishDate 2015-10-01
description Antibiotic resistance has become an urgent and global issue, with 700,000 deaths attributable to multidrug-resistance occurring each year worldwide. The overuse of antibiotics, both in animal industry and in clinical settings, and the generated selective pressure, are the main factors implicated in the emergence of resistant strains. The Centers for Disease Control and Prevention (CDC) have pointed out that more than half of hospital patients receive an antibiotic during their stay, and nearly a third receive a broad-spectrum antibiotic. In neonatal units, previous antibiotic exposure to third-generation cephalosporin and carbapenem were identified as independent risk factors for infection caused by multi-drug resistant strains. While resistant ‘superbugs’ emerge, the arsenal to fight these microorganisms is progressively shrinking, as the number of newly discovered antibiotics approved by the Food and Drug administration each year is dropping. In face of global spread of antibiotic resistance and of the limited development of new drugs, policies and rules are under study by agencies (CDC, World Health Organization) and governments, in order to: i) facilitate and foster the discovery of new antibiotic compounds; ii) develop new, alternative therapies able to potentiate or modulate the host immune response or to abrogate the resistance and virulence factors in the microorganisms; and iii) prevent the emergence of resistance through antibiotic stewardship programs, educational programs, and reduction of antibiotic use in livestock; the field of neonatal medicine will need its own, newborn-tailored, antibiotic stewardship programs to be implemented in the NICUs.   Proceedings of the 11th International Workshop on Neonatology and Satellite Meetings · Cagliari (Italy) · October 26th-31st, 2015 · From the womb to the adult Guest Editors: Vassilios Fanos (Cagliari, Italy), Michele Mussap (Genoa, Italy), Antonio Del Vecchio (Bari, Italy), Bo Sun (Shanghai, China), Dorret I. Boomsma (Amsterdam, the Netherlands), Gavino Faa (Cagliari, Italy), Antonio Giordano (Philadelphia, USA)
topic neonatal intensive care
infection
antibiotic
multi-drug resistant
carbapenemase
antibiotic stewardship
url https://www.jpnim.com/index.php/jpnim/article/view/333
work_keys_str_mv AT alessandroborghesi superbugsandantibioticsinthenewborn
AT maurostronati superbugsandantibioticsinthenewborn
_version_ 1725107736817958912